CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

Tonny Veenith; Benjamin A. Fisher; Daniel Slade; Anna Rowe; Rowena Sharpe; David R. Thickett; Tony Whitehouse; Matthew Rowland; James Scriven; Dhruv Parekh; Sarah J. Bowden; Joshua S. Savage; Duncan Richards; Julian Bion; Pamela Kearns; Simon Gates; on behalf of CATALYST investigators

doi:10.1101/2021.02.10.21251478

CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

Tonny Veenith, Benjamin A. Fisher, Daniel Slade, Anna Rowe, Rowena Sharpe, David R. Thickett, View ORCID ProfileTony Whitehouse, Matthew Rowland, James Scriven, Dhruv Parekh, Sarah J. Bowden, Joshua S. Savage, Duncan Richards, Julian Bion, Pamela Kearns, Simon Gates on behalf of CATALYST investigators

doi: https://doi.org/10.1101/2021.02.10.21251478

Tonny Veenith

1Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

2Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: t.v.veenith@bham.ac.uk b.fisher@bham.ac.uk

Benjamin A. Fisher

3Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

4National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: t.v.veenith@bham.ac.uk b.fisher@bham.ac.uk

Daniel Slade

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Rowe

4National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rowena Sharpe

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David R. Thickett

2Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

6Department of Respiratory Medicine, University Hospitals Birmingham NHS Trust, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tony Whitehouse

1Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

2Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Tony Whitehouse

Matthew Rowland

7Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James Scriven

8Department of Infectious Diseases, University Hospitals Birmingham NHS Trust, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dhruv Parekh

1Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

2Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, UK

6Department of Respiratory Medicine, University Hospitals Birmingham NHS Trust, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sarah J. Bowden

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joshua S. Savage

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Duncan Richards

9Oxford Clinical Trials Research Unit, Botnar Research Centre, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julian Bion

1Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pamela Kearns

4National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simon Gates

5Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

This manuscript is for a clinical trial protocol. As such there are no data referred to in the manuscript.

View the discussion thread.

PreviousNext

Posted February 12, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

Tonny Veenith, Benjamin A. Fisher, Daniel Slade, Anna Rowe, Rowena Sharpe, David R. Thickett, Tony Whitehouse, Matthew Rowland, James Scriven, Dhruv Parekh, Sarah J. Bowden, Joshua S. Savage, Duncan Richards, Julian Bion, Pamela Kearns, Simon Gates

medRxiv 2021.02.10.21251478; doi: https://doi.org/10.1101/2021.02.10.21251478

Share This Article:

Citation Tools

CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

medRxiv 2021.02.10.21251478; doi: https://doi.org/10.1101/2021.02.10.21251478

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Intensive Care and Critical Care Medicine

Subject Areas

All Articles

Addiction Medicine (381)
Allergy and Immunology (697)
Anesthesia (187)
Cardiovascular Medicine (2826)
Dentistry and Oral Medicine (324)
Dermatology (242)
Emergency Medicine (427)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1002)
Epidemiology (12526)
Forensic Medicine (10)
Gastroenterology (799)
Genetic and Genomic Medicine (4405)
Geriatric Medicine (399)
Health Economics (712)
Health Informatics (2835)
Health Policy (1044)
Health Systems and Quality Improvement (1042)
Hematology (373)
HIV/AIDS (893)
Infectious Diseases (except HIV/AIDS) (13942)
Intensive Care and Critical Care Medicine (827)
Medical Education (412)
Medical Ethics (114)
Nephrology (460)
Neurology (4161)
Nursing (220)
Nutrition (615)
Obstetrics and Gynecology (779)
Occupational and Environmental Health (720)
Oncology (2190)
Ophthalmology (623)
Orthopedics (254)
Otolaryngology (316)
Pain Medicine (264)
Palliative Medicine (81)
Pathology (484)
Pediatrics (1169)
Pharmacology and Therapeutics (486)
Primary Care Research (481)
Psychiatry and Clinical Psychology (3633)
Public and Global Health (6743)
Radiology and Imaging (1483)
Rehabilitation Medicine and Physical Therapy (863)
Respiratory Medicine (896)
Rheumatology (429)
Sexual and Reproductive Health (431)
Sports Medicine (362)
Surgery (471)
Toxicology (57)
Transplantation (198)
Urology (173)